Superparamagnetic Iron Oxide Nanoparticles (SPION): From Fundamentals to State-of-the-Art Innovative Applications for Cancer Therapy
Pharmaceutics · 10.01.2023 · 15 (1) · 236
DOI: 10.3390/pharmaceutics15010236 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pharmaceutics, online erschienen am 10.01.2023. Verfasst von Thomas Vangijzegem und 6 weiteren Autor:innen. Beteiligte Einrichtung: General, Organic and Biomedical Chemistry Unit, NMR and Molecular Imaging Laboratory, University of Mons, 7000 Mons, Belgium. Die Arbeit wurde bisher 235-mal zitiert (Crossref) und nennt 210 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Despite significant advances in cancer therapy over the years, its complex pathological process still represents a major health challenge when seeking effective treatment and improved healthcare. With the advent of nanotechnologies, nanomedicine-based cancer therapy has been widely explored as a promising technology able to handle the requirements of the clinical sector. Superparamagnetic iron oxide nanoparticles (SPION) have been at the forefront of nanotechnology development since the mid-1990s, thanks to their former role as contrast agents for magnetic resonance imaging. Though their use as MRI probes has been discontinued due to an unfavorable cost/benefit ratio, several innovative applications as therapeutic tools have prompted a renewal of interest. The unique characteristics of SPION, i.e., their magnetic properties enabling specific response when submitted to high frequency (magnetic hyperthermia) or low frequency (magneto-mechanical therapy) alternating magnetic field, and their ability to generate reactive oxygen species (either intrinsically or when activated using various stimuli), make them particularly adapted for cancer therapy. This review provides a comprehensive description of the fundamental aspects of SPION formulation and highlights various recent approaches regarding in vivo applications in the field of cancer therapy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General, Organic and Biomedical Chemistry Unit, NMR and Molecular Imaging Laboratory, University of Mons, 7000 Mons, Belgium.
- Center for Microscopy and Molecular Imaging (CMMI), Non-Ionizing Molecular Imaging Unit, 6041 Gosselies, Belgium.
ORCID-Profile: Thomas Vangijzegem, Valentin Lecomte, Dimitri Stanicki, Sophie Laurent
Zitieren
APA
Vangijzegem, T., Lecomte, V., Ternad, I., Van Leuven, L., Muller, R. N., Stanicki, D., & Laurent, S. (2023). Superparamagnetic Iron Oxide Nanoparticles (SPION): From Fundamentals to State-of-the-Art Innovative Applications for Cancer Therapy. Pharmaceutics, 15(1), 236. https://doi.org/10.3390/pharmaceutics15010236
Vancouver
Vangijzegem T, Lecomte V, Ternad I, Van Leuven L, Muller RN, Stanicki D, et al. Superparamagnetic Iron Oxide Nanoparticles (SPION): From Fundamentals to State-of-the-Art Innovative Applications for Cancer Therapy. Pharmaceutics. 2023;15(1):236. doi:10.3390/pharmaceutics15010236
BibTeX
@article{Vangijzegem2023,
author = {Vangijzegem, Thomas and Lecomte, Valentin and Ternad, Indiana and Van Leuven, Levy and Muller, Robert N and Stanicki, Dimitri and Laurent, Sophie},
title = {Superparamagnetic Iron Oxide Nanoparticles (SPION): From Fundamentals to State-of-the-Art Innovative Applications for Cancer Therapy},
journal = {Pharmaceutics},
year = {2023},
volume = {15},
number = {1},
pages = {236},
doi = {10.3390/pharmaceutics15010236}
}
EUVIMED